0001209191-24-003782.txt : 20240222 0001209191-24-003782.hdr.sgml : 20240222 20240222141948 ACCESSION NUMBER: 0001209191-24-003782 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20240220 FILED AS OF DATE: 20240222 DATE AS OF CHANGE: 20240222 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Byam Rebecca CENTRAL INDEX KEY: 0001866256 ORGANIZATION NAME: FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-40591 FILM NUMBER: 24664152 MAIL ADDRESS: STREET 1: C/O HCW BIOLOGICS, INC. STREET 2: 2929 N COMMERCE PKWY CITY: MIRAMAR STATE: FL ZIP: 33025 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: HCW Biologics Inc. CENTRAL INDEX KEY: 0001828673 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] ORGANIZATION NAME: 03 Life Sciences IRS NUMBER: 825024477 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 2929 N COMMERCE PKWY CITY: MIRAMAR STATE: FL ZIP: 33025 BUSINESS PHONE: 954-842-2024 MAIL ADDRESS: STREET 1: 2929 N COMMERCE PKWY CITY: MIRAMAR STATE: FL ZIP: 33025 4 1 doc4.xml FORM 4 SUBMISSION X0508 4 2024-02-20 0 0001828673 HCW Biologics Inc. HCWB 0001866256 Byam Rebecca C/O HCW BIOLOGICS INC 2929 N. COMMERCE PARKWAY MIRAMAR FL 33025 0 1 0 0 Chief Financial Officer 0 Common Stock 2024-02-20 4 A 0 760714 1.40 A 1381909 D The reporting person purchased these shares directly from the issuer in a private placement, which transaction is exempt from Section 16(b) in accordance with Rule 16b-3(d) promulgated under the Securities Exchange Act of 1934, as amended. /s/ Nicole Valdivieso, as Attorney-in-Fact for Rebecca A. Byam 2024-02-22